Pharma-Bio Serv Inc

pbsvinc.com

What Do They Do?

Provides regulatory, quality and technology-transfer consulting to pharmaceutical and biotechnology companies, medical-device makers and other manufacturers.

How Do They Make Money?

Clients are charged for consulting time, materials and project expenses at agreed rates, with revenue earned as work is performed; short-term fixed-fee projects are tied to milestones.

FY2025 revenue

Who Are Their Customers?

Pharmaceutical, chemical, medical-device, biotechnology, cosmetic and food companies hire the firm for consulting projects; project managers and senior staff market through existing and past client relationships and respond to prospective customers’ proposals.

Customers above 10% of revenue, FY2025

of revenue from three customers (17%, 12%, 12%)

FY2024: 42% from three customers

Do Revenues Turn Into Profits?

No. It lost $100.5K in FY2025.

Operating income, FY2025

−7% of revenue

▼ −50% (Loss) vs FY2024 (−$1.3M, −14%)

Net income, FY2025

−1% of revenue

▼ −87% (Loss) vs FY2024 (−$777.6K, −8%)

Free cash flow, FY2025

−2% of revenue

▼ −70% (Loss) vs FY2024 (−$726.4K, −8%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q3 FY2026, the three months to Jul 31, 2026

Revenue: ▲ +19%; vs $2M in Q3 FY2025
Net income: ▼ −93% (Loss); vs −$204.3K in Q3 FY2025

Shrinking. Revenue fell 55% in 4 years, from $20.1M in FY2021 to $9M in FY2025, about 18% a year.

Comments